EUVIMEDEUVIMED entdecken
Validierungsstudie

Validation of a risk stratification tool for SARS-CoV-2 Delta community transmission in the Australian Capital Territory

Alexandra Marmor, Tze Vun Voo, Meru Sheel, Timothy Sloan-Gardner, Nevada Pingault

Communicable Diseases Intelligence · 2024

DOI: 10.33321/cdi.2024.48.40 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Communicable Diseases Intelligence, 2024. Verfasst von Alexandra Marmor und 4 weiteren Autor:innen. Beteiligte Einrichtung: ACT Health, Canberra, Australia. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the SARS-CoV-2 Delta (B.1.617.2) variant outbreak, from August to October 2021 in the Australian Capital Territory (ACT), the number of new cases ‘in the community for part of their infectious period’ was publicly reported daily. We describe the stratification tool used during the outbreak to determine presumptive risk of community transmission from cases, and present the results of a contemporaneous validation of each case’s risk against their onward transmission detected by routine surveillance. After case interview, epidemiologists identified the most likely source of infection for each new case and used the stratification tool to classify the case as either no, low, or high risk of community transmission. Each case notified between 12 August and 14 September 2021 was matched to its recipient case(s) to determine how well the tool predicted transmission risk. Household transmissions were excluded. Of the 530 notified cases stratified, 159 (29.3%) were cases who transmitted to a recipient case. Of the 59 cases who were the source of community transmission, 66% (38/59) were undertaking high-risk activities not associated with permitted essential work at the time. Only six source cases stratified as low risk or no risk transmitted SARS-CoV-2 to those outside their own household. The tool was essential in the rapid determination of community transmission risk in the ACT, and validation of the tool against detected onward transmission provided evidence for the effectiveness of public health restrictions. In the early stages of outbreaks of diseases for which transmissibility has not yet been established, the validation of such a stratification tool relies on high quality case investigation data, but may help to understand transmission dynamics and to inform interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansAustralian Capital TerritoryRisk AssessmentDisease OutbreaksFemaleMaleAdultMiddle AgedCommunity-Acquired InfectionsAged

Stichwörter der Autor:innen

Australian Capital TerritoryCOVID-19SARS-CoV-2 Deltaepidemiologyrisk stratificationtransmission

Autor:innen und Institutionen

  • ACT Health, Canberra, Australia.
  • Sydney School of Public Health, University of Sydney, NSW, Australia.
  • Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, NSW Australia.
  • National Centre for Epidemiology and Public Health, Australian National University, Canberra, Australia.

Zitieren

APA

Marmor, A., Voo, T. V., Sheel, M., Sloan-Gardner, T., & Pingault, N. (2024). Validation of a risk stratification tool for SARS-CoV-2 Delta community transmission in the Australian Capital Territory. Communicable Diseases Intelligence. https://doi.org/10.33321/cdi.2024.48.40

Vancouver

Marmor A, Voo TV, Sheel M, Sloan-Gardner T, Pingault N. Validation of a risk stratification tool for SARS-CoV-2 Delta community transmission in the Australian Capital Territory. Communicable Diseases Intelligence. 2024. doi:10.33321/cdi.2024.48.40

BibTeX
@article{Marmor2024,
  author = {Marmor, Alexandra and Voo, Tze Vun and Sheel, Meru and Sloan-Gardner, Timothy and Pingault, Nevada},
  title = {Validation of a risk stratification tool for SARS-CoV-2 Delta community transmission in the Australian Capital Territory},
  journal = {Communicable Diseases Intelligence},
  year = {2024},
  doi = {10.33321/cdi.2024.48.40}
}
Kostenlos starten →